Post-Brexit Divergence Would Harm UK Industry

BGMA Director General Warwick Smith Talks Brexit Implications

On the eve of the UK’s formal exit from the EU on 31 January, BGMA director general Warwick Smith has insisted that it is essential for the UK to stay as close as possible to the current European medicines framework following the conclusion of a transition period that is currently due to expire at the end of 2020.

Arrow_Flags_Pavement
Divergence from the European framework would harm industry and patients • Source: Shutterstock

Departing from the European regulatory framework for medicines following the UK’s exit from the EU would pose a significant risk for both the UK off-patent industry and for patient access to affordable medicines, according to Warwick Smith, director general of the British Generic Manufacturers Association and the British Biosimilars Association.

Speaking to Generics Bulletin just ahead of the UK’s formal departure from the EU, Smith noted that, for the moment,...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Regulation

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.